Antimicrobial
Pyrazinamide
Acid-pH prodrug via pncA activation
peer-uh-ZIN-uh-mide
High-yield clue
Pyrazinamide is activated by pncA to pyrazinoic acid and works best in acidic conditions, and pncA mutation is the main resistance route.
Overview
An antimycobacterial prodrug studied for activation by mycobacterial pyrazinamidase (pncA) to pyrazinoic acid, with activity favored in acidic environments.
Classification
- Antimycobacterial prodrug
- Activated by pyrazinamidase (pncA)
- Yields pyrazinoic acid
- Active in acidic intracellular environment
Lab & identification clues
- pncA mutation resistance vocabulary
- Pyrazinoic acid accumulation at acid pH concept
- Sterilizing activity against semi-dormant bacilli concept
Associations
- Tuberculosis regimen shortening study vocabulary
- Hyperuricemia / joint symptom concept
- Hepatotoxicity monitoring study framing
Commonly confused with
- Isoniazid
- Ethambutol
Frequently asked questions
What is Pyrazinamide?
An antimycobacterial prodrug studied for activation by mycobacterial pyrazinamidase (pncA) to pyrazinoic acid, with activity favored in acidic environments.
What is the high-yield clue for Pyrazinamide?
Pyrazinamide is activated by pncA to pyrazinoic acid and works best in acidic conditions, and pncA mutation is the main resistance route.
What is Pyrazinamide associated with?
Pyrazinamide is associated with Tuberculosis regimen shortening study vocabulary, Hyperuricemia / joint symptom concept, and Hepatotoxicity monitoring study framing.
What is Pyrazinamide commonly confused with?
Pyrazinamide is commonly confused with Isoniazid and Ethambutol.
Original mechanism summary for microbiology study. Sources checked: CDC antimicrobial-resistance guidance, NCBI Bookshelf Medical Microbiology, and standard coursework frameworks; reviewed 2026-06. Covers class, mechanism, and resistance vocabulary only; no prescribing, dosing, or patient-specific treatment guidance.